Spots Global Cancer Trial Database for Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Official Title: Evaluation of IRDye800CW-nimotuzumab in Lung Cancer Surgery
Study ID: NCT04459065
Conditions
Interventions
Study Description
Brief Summary: The purpose of this study is to determine the safety, optimal dose and imaging time of the investigational product, IRDye800CW-nimotuzumab for use as a near infrared imaging probe for image-guided surgery during lung cancer resection. IRDye800CW-nimotuzumab targets cancer cells over-expressing EGFR, allowing tumors to be visualized and may help surgeons better identify cancer during surgery.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
St. Paul's Hospital, Saskatoon, Saskatchewan, Canada
Contact Details
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
